Trial intelligence / Profile preview

Vitravene (fomivirsen) in advanced CMV retinitis

NCT00002187Phase 3Completed

Sponsor
Ionis Pharmaceuticals
Countries
1
01

Overview

A Phase 3 trial of fomivirsen in cytomegalovirus retinitis, sponsored by Ionis Pharmaceuticals. Status: completed.

02

Drugs

fomivirsen
03

Conditions

cytomegalovirus retinitis

Beyond the preview

Go deeper on NCT00002187.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002187.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call